Fundraising

Across the globe, Mendel Partners help Rare Disease and Advanced Therapies start-up businesses to identify, attract, and secure interest from multiple investors relevant to their business needs, whilst offsetting the fee-for-service against the raise itself, effectively making it a 'free' service.

Utilising our established advanced therapies and orphan drug investor network, deep research-led search methods, and highly personalised sourcing tactics, we can help you identify, attract and secure interest from multiple investors relevant to your business, who are well-placed to bring you success.

This meaningfully impacts;

Outreach to eloquent investors
Outreach:Meeting hit rate
Acceleration towards funding
Volume of interested investors

Access to genuine investor feedback
Strength of negotiating position
Expanded access to onward investor networks
Influential pre-meeting investor insights

Our Process

Stage 1 - Investor readiness

Definition of investor target criteria & raise strategy
Target investor landscape mapping
Initial outreach & pre-qualification of fund criteria
Pre-presentation quality positioning in preparation of Phase 2 Pitch & Present
Shortlisting of relevant target investors in preparation of Phase 2 (i.e. no pitch or presentation of slide decks until Phase 2)